SCHEMBL30664684

SCHEMBL30664684

CC(=O)N(Cc1ccccc1)c1sc2cc(O)ccc2c1C(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSPO P30536 2/20 0.39
▸ AKT1 P31749 3/20 0.37
▸ PDK1 Q15118 3/20 0.36
▸ GRM6 O15303 1/20 0.35
▸ DYRK1A Q13627 1/20 0.35
▸ ESR1 P03372 1/20 0.35
▸ ESR2 Q92731 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ SLC7A5 Q01650 1/20 0.34
▸ PDK2 Q15119 1/20 0.34
▸ PDK4 Q16654 1/20 0.34
▸ STAT5B P51692 1/20 0.34
▸ NR1H2 P55055 1/20 0.33
▸ NR1H3 Q13133 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24682934 1.00 TSPO (0.39) TSPOAKT1PDK1GRM6DYRK1A
SCHEMBL24682178 0.89 MAPT (0.43) TSPOPDK1DYRK1AESR1ESR2
SCHEMBL29800041 0.89 MAPT (0.43) TSPOPDK1DYRK1AESR1ESR2
SCHEMBL29799804 0.88 TSPO (0.44) TSPOPDK1DYRK1AESR1ESR2
SCHEMBL24682174 0.88 TSPO (0.44) TSPOPDK1DYRK1AESR1ESR2
SCHEMBL24683154 0.87 LMNA (0.45) TSPOPDK1MEN1KMT2AL3MBTL1
SCHEMBL29800048 0.87 LMNA (0.45) TSPOPDK1MEN1KMT2AL3MBTL1
SCHEMBL24682961 0.86 POLB (0.39) TSPOPDK1DYRK1AESR1ESR2
SCHEMBL30664676 0.86 POLB (0.39) TSPOPDK1DYRK1AESR1ESR2
SCHEMBL24682194 0.84 TSPO (0.42) TSPOPDK1DYRK1AESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY OTCPHARM JSC (RU) 2024-05-30 — — US disclosed
EP-4293017-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY Otcpharm JSC (RU) 2023-12-20 — — EP disclosed
CN-117222630-A 2-acetamido-6-hydroxy-benzothiophene derivatives having antiviral activity OTC制药公司(JSC) 2023-12-12 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY ACE2, ACE, EIF2AK2 TSPO 4234/4885AKT1 4140/4885PDK1 1882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback